Publisher
Springer Science and Business Media LLC
Reference28 articles.
1. Sitohy, B., Nagy, J. A. & Dvorak, H. F. Anti-VEGF/VEGFR therapy for cancer: reassessing the target. Cancer Res. 72, 1909–1914, doi: 10.1158/0008-5472.CAN-11-3406 (2012).
2. Vasudev, N. S. & Reynolds, A. R. Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions. Angiogenesis 17, 471–494, doi: 10.1007/s10456-014-9420-y (2014).
3. Jain, R. K. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 307, 58–62, doi: 10.1126/science.1104819 (2005).
4. Browder, T. et al. Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer. Cancer Res. 60, 1878–1886 (2000).
5. Kerbel, R. S. Tumor angiogenesis: past, present and the near future. Carcinogenesis 21, 505–515, doi: 10.1093/carcin/21.3.505 (2000).
Cited by
28 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献